Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 33, 2021 - Issue 3
362
Views
8
CrossRef citations to date
0
Altmetric
Articles

Changes in body mass index among people living with HIV who are new on highly active antiretroviral therapy: a systematic review and meta-analysis

, , , , &
Pages 326-336 | Received 09 Aug 2019, Accepted 12 May 2020, Published online: 28 May 2020

References

  • Abrahams, Z., Levitt, N., Lesosky, M., Maartens, G., & Dave, J. (2016). Changes in body fat distribution on dual-energy X-ray absorptiometry in black South Africans starting first-line antiretroviral therapy. AIDS Patient Care and STDs, 30(10), 455–462. https://doi.org/10.1089/apc.2016.0183
  • Achhra, A. C., Mocroft, A., Reiss, P., Sabin, C., Ryom, L., de Wit, S., Smith, C. J., d’Arminio Monforte, A., Phillips, A., Weber, R., Lundgren, J., & Law, M. G. (2016). Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D:A:D study. HIV Medicine, 17(4), 255–268. https://doi.org/10.1111/hiv.12294
  • Akinboro, A. O., Onayemi, O., Ayodele, O. E., Mejiuni, A. D., & Atiba, A. S. (2013). The impacts of first line highly active antiretroviral therapy on serum selenium. CD, 4, count, and body mass index: A cross sectional and short prospective study. Pan African Medical Journal, 15, 97. doi:10.11604/pamj.2013.15.97.2524.
  • Amorosa, V., Synnestvedt, M., Gross, R., Friedman, H., MacGregor, R. R., Gudonis, D., Frank, I., & Tebas, P. (2005). A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. Journal of Acquired Immune Deficiency Syndromes, 39(5), 557–561. doi:10.1097/01.qai.0000171638.9b.
  • Armah, K. A., Chang, C. C., Baker, J. V., Ramachandran, V. S., Budoff, M. J., Crane, H. M., Gibert, C. L., Goetz, M. B., Leaf, D. A., McGinnis, K. A., Oursler, K. K., Rimland, D., Rodriguez-Barradas, M. C., Sico, J. J., Warner, A. L., Hsue, P. Y., Kuller, L. H., Justice, A. C., & Freiberg, M. S. (2013). Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans. Clinical Infectious Diseases, 58(1), 121–129. https://doi.org/10.1093/cid/cit652
  • Bala, B., Majumdar, B. B., Pal, J., Datta, S., Talukdar, A., & Das, S. (2016). Study of metabolic complications after 1 year of antiretroviral therapy in HIV-infected patients in a tertiary care center in North Bengal. Annals of Tropical Medicine and Public Health, 9(2), 97–101. https://doi.org/10.4103/1755-6783.177376
  • Bezabhe, W. M., Bereznicki, L. R., Chalmers, L., Gee, P., Kassie, D. M., Bimirew, M. A., & Peterson, G. M. (2015). Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: A prospective cohort study from Ethiopia. Drug Safety, 38(7), 629–639. https://doi.org/10.1007/s40264-015-0295-7
  • Bonnet, E., Ruidavets, J. B., Genoux, A., Mabile, L., Busato, F., Obadia, M., Prévoteau, F., Marchou, B., Massip, P., Marion-Latard, F., Delpierre, C., Bernard, J., & Perret, B. (2013). Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: The prospective Lipotrip study. BMC Infectious Diseases, 13(1), 293. https://doi.org/10.1186/1471-2334-13-293
  • Crum-Cianflone, N., Tejidor, R., Medina, S., Barahona, I., & Ganesan, A. (2008). Obesity among patients with HIV: The latest epidemic. AIDS Patient Care and STDs, 22(12), 925–930. https://doi.org/10.1089/apc.2008.0082
  • Denue, B. A., Ikunaiye, P. N. Y., & Denue, C. B. A. (2013). Body mass index changes during highly active antiretroviral therapy in Nigeria. Eastern Mediterranean Health Journal, 19(3), S89–S97.
  • Dirajlal-Fargo, S., Moser, C., Brown, T. T., Kelesidis, T., Dube, M. P., Stein, J. H., Currier, J., & McComsey, G. A. (2016). Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infectious Diseases, 3(3), ofw174. https://doi.org/10.1093/ofid/ofw174
  • Effective Public Health Practice Project (EPHPP). (2010). Quality assessment tool for quantitative studies. http://www.ephpp.ca/PDF/QualityAssessment Tool_2010_2.pdf
  • Erlandson, K. M., Taejaroenkul, S., Smeaton, L., Gupta, A., Singini, I. L., Lama, J. R., Mngqibisa, R., Firnhaber, C., Cardoso, S. W., Kanyama, C., Machado da Silva, A. L., Hakim, J. G., Kumarasamy, N., Campbell, T. B., & Hughes, M. D. (2015). A randomized comparison of anthropomorphic changes with preferred and alternative efavirenz-based antiretroviral regimens in diverse multinational settings. Open Forum Infectious Diseases, 2(3), ofv095. https://doi.org/10.1093/ofid/ofv095
  • Esposito, F. M., Coutsoudis, A., Visser, J., & Kindra, G. (2008). Changes in body composition and other anthropometric measures of female subjects on highly active antiretroviral therapy (HAART): A pilot study in Kwazulu-Natal, South Africa. Southern African Journal of Medicine. Spring, 2008.
  • Evans, D., McNamara, L., Maskew, M., Selibas, K., van Amsterdam, D., Baines, N., Webster, T., & Sanne, I. (2013). Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy. Nutrition Journal, 12(1), 111. https://doi.org/10.1186/1475-2891-12-111
  • George, J. A., Venter, W. D., Van Deventer, H. E., & Crowther, N. J. (2009). A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine. AIDS Research and Human Retroviruses, 25(8), 771–781. https://doi.org/10.1089/aid.2008.0308
  • Gil, L., Tarinas, A., Hernández, D., Riverón, B. V., Pérez, D., Tápanes, R., Capo, V., & Pérez, J. (2010). Altered oxidative stress indexes related to disease progression marker in human immunodeficiency virus infected patients with antiretroviral therapy. Biomedicine & Aging Pathology, 1(1), 8–15. https://doi.org/10.1016/j.biomag.2010.09.001
  • Grant, P. M., Kitch, D., McComsey, G. A., Collier, A. C., Bartali, B., Koletar, S. L., Erlandson, K. M., Lake, J. E., Yin, M. T., Melbourne, K., Ha, B., & Brown, T. T. (2016). Long-term body composition changes in antiretroviral-treated HIV-infected individuals. Aids (London, England), 30(18), 2805–2813. https://doi.org/10.1097/QAD.0000000000001248
  • Guehi, C., Badjé, A., Gabillard, D., Ouattara, E., Koulé, S. O., Moh, R., Ekouevi, D., Ahibo, H., N’Takpé, J. B., Menan, G. K., Deschamps, N., Lecarrou, J., Eholié, S., Anglaret, X., & Danel, C. (2016). High prevalence of being overweight and obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial. AIDS Research and Therapy, 13(1), 12. https://doi.org/10.1186/s12981-016-0094-y
  • Gupta, V., Biswas, A., & Sharma, S. K. (2011). Metabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patients. International Journal of STD & AIDS, 22(1), 46–49. https://doi.org/10.1258/ijsa.2010.010193
  • Hasse, B., Iff, M., Ledergerber, B., Calmy, A., Schmid, P., Hauser, C., Bernasconi, E., Böni, J., Bucher, H. C., Burton-Jeangros, C., Calmy, A., Cavassini, M., Egger, M., Elzi, L., Fehr, J., Fellay, J., Furrer, H., Fux, C. A., Gorgievski, M., … Yerly, S. (2014). Obesity trends and body mass index changes after starting antiretroviral treatment: The Swiss HIV Cohort study. Open Forum Infectious Diseases, 1(2), ofu040. https://doi.org/10.1093/ofid/ofu040
  • Herrin, M., Tate, J. P., Akgün, K. M., Butt, A. A., Crothers, K., Freiberg, M. S., Gibert, C. L., Leaf, D. A., Rimland, D., Rodriguez-Barradas, M. C., Ruser, C. B., Herold, K. C., & Justice, A. C. (2016). Weight gain and incident diabetes among HIV-infected Veterans initiating antiretroviral therapy compared with uninfected individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes, 73(2), 228–236. https://doi.org/10.1097/QAI.0000000000001071
  • Higgins, J. P. T., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions, Version 5.1.0. http://handbook-5-1.cochrane.org/
  • Huisin 't Veld, D., Balestre, E., Buyze, J., Menten, J., Jaquet, A., Cooper, D. A., Dabis, F., Yiannoutsos, C. T., Diero, L., Mutevedzi, P., Fox, M. P., Messou, E., Hoffmann, C. J., Prozesky, H. W., Egger, M., Hemingway-Foday, J. J., & Colebunders, R. (2015). Determinants of weight evolution among HIV-positive patients initiating antiretroviral treatment in low-resource settings. JAIDS Journal of Acquired Immune Deficiency Syndromes, 70(2), 146–154. https://doi.org/10.1097/QAI.0000000000000691
  • Hurley, E., Coutsoudis, A., Giddy, J., Knight, S. E., Loots, E., & Esterhuizen, T. M. (2011). Weight evolution and perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African urban setting. South African Medical Journal, 101(9), 645–650.
  • Ioannidis, J. P., Patsopoulos, N. A., & Rothstein, H. R. (2008). Reasons or excuses for avoiding meta-analysis in forest plots. BMJ, 336(7658), 1413–1415. https://doi.org/10.1136/bmj.a117
  • Joint United Nations Programme on HIV/AIDS [UNAIDS]. (2018). Global HIV & AIDS statistics — 2018 fact sheet. http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
  • Jones, C. Y., Hogan, J. W., Snyder, B., Klein, R. S., Rompalo, A., Schuman, P., & Carpenter, C. C. (2003). Overweight and human immunodeficiency virus (HIV) progression in women: Associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clinical Infectious Diseases, 37(2), S69–S80. https://doi.org/10.1086/375889
  • Kalofonos, I. A. (2010). “All I Eat Is ARVs”: The paradox of AIDS treatment interventions in Central Mozambique. Medical Anthropology Quarterly, 24(3), 363–380. https://doi.org/10.1111/j.1548-1387.2010.01109.x
  • Koethe, J. R., Jenkins, C. A., Lau, B., Shepherd, B. E., Justice, A. C., Tate, J. P., Buchacz, K., Napravnik, S., Mayor, A. M., Horberg, M. A., Blashill, A. J., Willig, A., Wester, C. W., Silverberg, M. J., Gill, J., Thorne, J. E., Klein, M., Eron, J. J., Kitahata, M. M., … Moore, R. D. (2015). Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada. AIDS Research and Human Retroviruses, 32(1), 50–58. https://doi.org/10.1089/aid.2015.0147
  • Kumar, S., & Samaras, K. (2018). The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality. Frontiers in Endocrinology, 9, 705. https://doi.org/10.3389/fendo.2018.00705
  • Lakey, W., Yang, L. Y., Yancy, W., Chow, S. C., & Hicks, C. (2013). Short communication: From wasting to obesity: Initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Research and Human Retroviruses, 29(3), 435–440. https://doi.org/10.1089/aid.2012.0234
  • Maia Leite, L. H., & De Mattos Marinho Sampaio, A. B. (2010). Progression to overweight, obesity and associated factors after antiretroviral therapy initiation among Brazilian persons with HIV/AIDS. Nutrición Hospitalaria, 25(4), 635–640.
  • Messou, E., Gabillard, D., Moh, R., Inwoley, A., Sorho, S., Eholié, S., Rouet, F., Seyler, C., Danel, C., & Anglaret, X. (2008). Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in West African adults. Bulletin of the World Health Organization, 86(6), 435–442. doi:10.2471/BLT.07.042911.
  • Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., Altman, D., Antes, G., … Tugwell, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), 264–269. https://doi.org/10.1371/journal.pmed.1000097
  • Moyle, G. J., Hardy, H., Farajallah, A., DeGrosky, M., & McGrath, D. (2014). Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naive patients with HIV-1 infection. Clinical Drug Investigation, 34(4), 287–296. https://doi.org/10.1007/s40261-014-0175-4
  • Mutimura, E., Hoover, D. R., Shi, Q., Dusingize, J. C., Sinayobye, J. D., Cohen, M., & Anastos, K. (2015). Insulin resistance change and antiretroviral therapy exposure in HIV-infected and uninfected Rwandan women: A longitudinal analysis. PLoS ONE, 10(4), e0123936. https://doi.org/10.1371/journal.pone.0123936
  • Ncube, R. T., Hwalima, Z., Tshimanga, M., Chirenda, J., Mabaera, B., & Apollo, T. (2008). Treatment outcomes of patients on antiretrovirals after six months of treatment, Khami clinic, Bulawayo, Zimbabwe. Central African Journal of Medicine, 54(1–4), 8–15.
  • Nduka, C. U., Uthman, O. A., Kimani, P. K., & Stranges, S. (2016). Body fat changes in people living with HIV on antiretroviral therapy. AIDS Reviews, 18(4), 198–211.
  • Saghayam, S., Kumarasamy, N., Cecelia, A. J., Solomon, S., Mayer, K., & Wanke, C. (2007). Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India. Clinical Infectious Diseases, 44(2), 295–300. https://doi.org/10.1086/510491
  • Sarna, A., Luchters, S., Geibel, S., Chersich, M. F., Munyao, P., Kaai, S., Mandaliya, K. N., Shikely, K. S., Temmerman, M., & Rutenberg, N. (2008). Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: A randomized trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(5), 611–619. https://doi.org/10.1097/QAI.0b013e3181806bf1
  • Tang, A. M., Sheehan, H. B., Jordan, M. R., Duong, D. V., Terrin, N., Dong, K., Trinh Thi Minh Lien, Nguyen Vu Trung, Christine A. Wanke, Hien, N. D. (2011). Predictors of weight change in male HIV-positive injection drug users initiating antiretroviral therapy in Hanoi, Vietnam. AIDS Research and Treatment, 890308.
  • Taramasso, L., Ricci, E., Menzaghi, B., Orofino, G., Passerini, S., Madeddu, G., Martinelli, C. V., De Socio, G. V., Squillace, N., Rusconi, S., Bonfanti, P., Di Biagio, A., Quirino, T., Bonfanti, P., Ricci, E., Bellacosa, C., Maggi, P., Calza, L., Abeli, C., … Caramell, P. (2017). Weight gain: A possible side effect of all antiretrovirals. Open Forum Infectious Diseases, 4(4), ofx239. https://doi.org/10.1093/ofid/ofx239
  • Tate, T., Willig, A. L., Willig, J. H., Raper, J. L., Moneyham, L., Kempf, M.-C., Saag, M. S., & Mugavero, M. J. (2012). HIV infection and obesity: Where did all the wasting go? Antiviral Therapy, 17(7), 1281–1289. https://doi.org/10.3851/IMP2348
  • Tiéno, H., Guira, O., Sagna, Y., Diendéré, E. A., Diallo, I., Bognounou, R., Zoungrana, L., Zida, S., Nikiéma, P., & Drabo, Y. J. (2015). Characteristics and follow-up of newly managed HIV-infected patients in the national referral center in Ouagadougou, Burkina Faso. Journal of the International Association of Providers of AIDS Care (JIAPAC), 14(1), 40–45. https://doi.org/10.1177/2325957412470722
  • van Oosterhout, J. J., Ndekha, M., Moore, E., Kumwenda, J. J., Zijlstra, E. E., & Manary, M. (2010). The benefit of supplementary feeding for wasted Malawian adults initiating ART. AIDS Care, 22(6), 737–742. https://doi.org/10.1080/09540120903373581
  • The World Bank Group. (2019). World Bank country and lending groups: Country classification. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
  • Yuh, B., Tate, J., Butt, A. A., Crothers, K., Freiberg, M., Leaf, D., Logeais, M., Rimland, D., Rodriguez-Barradas, M. C., Ruser, C., & Justice, A. C. (2015). Weight change after antiretroviral therapy and mortality. Clinical Infectious Diseases, 60(12), 1852–1859. https://doi.org/10.1093/cid/civ192

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.